Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
7543- HT,    Hydroxytyrosol supplementation increases vitamin C levels in vivo. A human volunteer trial
- Trial, Nor, NA
VitC↑,
7526- HT,    Hydroxytyrosol in functional hydroxytyrosol-enriched biscuits is highly bioavailable and decreases oxidised low density lipoprotein levels in humans
- Trial, Nor, NA
*Half-Life↝, *BioAv↑, *Dose↝, *BioAv↝,
7536- HT,    Effects of Desert Olive Tree Pearls Containing High Hydroxytyrosol Concentrations on the Cognitive Functions of Middle-Aged and Older Adults
- Trial, AD, NA
*Dose↑, *motorD↑, *cognitive↑, *Dose↝,
7541- HT,    Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer
- Trial, BC, NA
Dose↝, MMP9↓, TIMP1↓,
4635- HT,    Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer
- Trial, BC, NA
*Wnt↓, *NOTCH↓, *ROS↓, TumCP↓, CSCs↓,
7479- Hup,    A phase II trial of huperzine A in mild to moderate Alzheimer disease
- Trial, AD, NA
*Dose↝, *cognitive↑, *eff∅, *AChE↓,
7480- Hup,    Pharmacokinetics of huperzine A following oral administration to human volunteers
- Trial, AD, NA
*Dose↝, *BioAv↝, *Half-Life↝,
7602- I3C,    Dose-ranging study of indole-3-carbinol for breast cancer prevention
- Trial, BC, NA
toxicity↓, Dose↝, 2/16-OHE1↑, chemoPv↑,
7611- I3C,    Long-term responses of women to indole-3-carbinol or a high fiber diet
- Trial, Nor, NA
*Dose↝, *2/16-OHE1↑,
7580- I3C,    Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane
- Trial, NA, NA
Dose↝, BioAv↝, Dose↝,
7581- I3C,    A phase I study of indole-3-carbinol in women: tolerability and effects
- Trial, Nor, NA
CYP1A2↑, Dose↝,
7578- IMA,    Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
- Trial, CML, NA
OS↑, toxicity↓, BCR-ABL↓,
7579- IMA,    One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
- Trial, GC, NA
RFS↑, OS↑,
7616- Ins,    A phase I study of myo-inositol for lung cancer chemoprevention
- Trial, Nor, NA
*Dose↝, *toxicity↝, *BP↓,
7634- Ins,    Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
- Trial, Nor, NA
*BioAv↓,
7643- Ins,  IP6,    Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud
- Trial, BC, NA
RBC↑, QoL↑, eff↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,
7633- Ins,    Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use
- Trial, Nor, NA
*BioAv↑, *toxicity↓,
7673- iod,  Chemo,    Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
- Trial, BC, NA
Dose↝, *chemoP↑,
7672- iod,    Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
- Trial, BC, NA
Dose↝, OS↑, TumCI↓, Apoptosis↑, EstroRS/ERS↑, eff↑, *cardioP↑, *antiOx↑, *Inflam↓,
7684- iod,    Molecular iodine impairs chemotherapy resistance and adverse effects in breast cancer treatments
- Trial, BC, NA
Dose↝, OS↑, antiNeop↑, eff↑,
7661- IP,    Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial
- Trial, Nor, NA
*PA↑, *Buty↑, *GutMicro↑, *SCFAs↑,
7662- IP,    Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers
- Trial, Nor, NA
Dose↝, toxicity↓,
7664- IP,  GCL2505,    Administration of bifidobacteria and dietary fiber improves cognitive function by increasing short-chain fatty acid-producing bacteria and reducing inflammation
- Trial, AD, NA
*cognitive↑, *SCFAs↑, *GutMicro↑, *Buty↑, *AcOH↑, *neuroP↑,
7665- IP,    A Prebiotic-Supplemented Formula Improves Gut Microbiota and Intestinal Inflammatory Microenvironment in Patients with Colorectal Adenoma: A Double-Blind, Placebo-Controlled Trial
- Trial, Nor, NA
*GutMicro↑, *Inflam↓,
7666- IP,    Short-chain fatty acid kinetics and concentrations are higher after inulin supplementation in young and older adults: a randomized trial
- Trial, Nor, NA
*Dose↝, *Buty↑, *PA↑, *AcOH↑, *SCFAs↑,
7668- IP,    A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis
- Trial, Sepsis, NA
*Dose↝, *SCFAs∅, *GutMicro∅, *other↝,
7640- IP6,  Ins,    Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy
- Trial, BC, NA
*antiOx↑, QoL↑, RBC↑, HemoG↑, WBC↑, chemoP↑, Dose↝,
7741- isoFl,  Lyco,  SIL,    Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement
- Trial, Pca, NA
Dose↝, PSA↓,
7740- isoFl,    Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial
- Trial, Pca, NA
Dose↝, Risk∅,
7738- isoFl,    Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced pro-inflammatory cytokines and immune suppressive cells
- Trial, Pca, NA
Dose↝, CD4+↓, CD25+↓, FoxP3+↓, other↓, Inflam↓, CSCs↓, other↝,
7731- isoFl,    Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial
- Trial, AD, NA
*cognitive∅, *memory↑,
7850- ISQ,    Effect of quercetin glycosides on cognitive functions and cerebral blood flow: a randomized, double-blind, and placebo-controlled study
- Trial, Nor, NA
*Dose↝, *RT↓, *BloodF↑, *Aβ↓,
7996- itraC,    Itraconazole in the Treatment of Aberrantly Active Hedgehog and/or PI3K Recurrent Ovarian Cancer
- Trial, Ovarian, NA
HH↓, PI3K↓, toxicity↝, eff∅, CA125∅, other↝,
7991- itraC,    A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low-Risk Basal Cell Carcinoma
- Trial, BCC, NA
Smo↓, Dose↓, TumVol↓, Endoglin↓, angioG↓, toxicity↝, GLI3↓, toxicity↓,
7990- itraC,    A Novel Approach to Reducing Chemoresistance in Advanced Ovarian Cancer: The Effect of Itraconazole-A Single-Institution Randomized Placebo-Controlled Trial
- Trial, Ovarian, NA
Dose↝, DCR↑, PFS↑, CA125↓, P-gp/ABCB1↓, VEGFR2/KDR/Flk1↑, toxicity↓, QoL↑, toxicity↝,
7989- itraC,    Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer
- Trial, NSCLC, NA
Dose↝, TumVol↓, angioG↓, IL1β↓, GM-CSF↓, HH∅, BioAv↝, other↝,
7988- itraC,    Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
- Trial, Pca, NA
PSA↓, toxicity↝, testos∅, toxicity↝,
7987- itraC,    Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer
- Trial, Pca, NA
angioG↓, HH↓, Dose↝, PSA↓, CTC↓, other↝, toxicity↝,
7986- itraC,    Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma
- Trial, BCC, NA
Dose↝, TumCP↓, HH↓, TumVol↓, SD↑,
8018- itraC,  Chemo,    Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer
- Trial, Ovarian, NA
PFS↑, OS↑, other↝,
8058- KAE,    A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone
- Trial, Nor, NA
*AntiBio↑, *antiOx↑, *Inflam↓, *AntiTum↑, *AntiDiabetic↑, *cardioP↑, *neuroP↑, *Dose↝, *toxicity↓,
8109- L-Orn,    Effects of Oral Ingestion of L-Ornithine on Mental Stress and Fatigue Based on the Trier Social Stress Test in Healthy Humans: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
- Trial, Nor, NA
*cortisol↓, *Stress↓, *Dose↝, *fatigue↓,
8110- L-Orn,    L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism
- Trial, Nor, NA
*Dose↝, *KeyT↝, *FFA/NEFA↝, *NH3↓, *fatigue↓,
8119- LA,    Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial
- Trial, CRC, NA
Inf↓, Inf↓,
8117- LA,  ProBio,    The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial
- Trial, CRC, NA
Dose↝, Inf↓, ZO-1↓, other↓,
8118- LA,  ProBio,    Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study
- Trial, CRC, NA
Inf↓, IBI↑, Dose↝, Diar↓,
1272- LA,    Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
- Trial, Nor, NA
*Pain↓, *other↑,
8158- lamb,    Effect of Pinus koraiensis leaf extract on fatigue reduction and exercise performance: study protocol for a randomized, double-blind, placebo-controlled clinical trial
- Trial, Nor, NA
*Strength↑, *lactateProd↓, *LDH↓, *CK2↓,
8172- Lap,    Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study
- Trial, BC, NA
BioAv↑, eff↑,
8171- Lap,    Effects of food on the relative bioavailability of lapatinib in cancer patients
- Trial, Var, NA
BioAv↝, Dose↝,

Showing Research Papers: 251 to 300 of 435
Prev Page 6 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 435

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

2/16-OHE1↑, 1,   8-oxo-dG↓, 1,   ADCY4↑, 1,   AEs∅, 1,   APG↓, 2,   CIT↓, 1,   CR↑, 2,   DCR↑, 3,   DCR↝, 1,   ENL↑, 1,   IGF-2R↑, 1,   Ingr↑, 1,   JAG1↑, 1,   LC↑, 1,   mal↓, 1,   miR-106b↓, 1,   Mucositis↓, 4,   Nausea↓, 4,   Nausea∅, 2,   NEU1↑, 1,   NLR↓, 1,   ORR↑, 3,   ORR∅, 1,   PC↑, 3,   PFS↑, 4,   PFS∅, 1,   PGI2↓, 1,   RBC↑, 3,   RFS↑, 1,   TTP↑, 1,   UFR↑, 1,   Vomit↓, 4,   Vomit∅, 2,   WBC↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   MPT↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   BUN↓, 1,   CYP3A4⇅, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,   PPARγ↓, 1,  

Cell Death(tgid=5) ⓘ

p‑Akt↓, 1,   Apoptosis↑, 6,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   Myc↓, 1,   NOXA↑, 1,   PUMA↑, 1,   survivin↓, 1,   TRPV1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

miR-30a-5p↑, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 18,   other∅, 3,   SD↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 2,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HDAC↓, 4,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   IGFR↓, 1,   NOTCH3↑, 1,   PI3K↓, 1,   PTEN↑, 2,   Smo↓, 1,   TumCG↓, 7,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 1,   AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   Ki-67↓, 6,   miR-19b↓, 1,   miR-29b↑, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 1,   TumCI↓, 3,   TumCMig↓, 2,   TumCP↓, 9,   TumMeta↓, 1,   TumMeta↑, 1,   Twist↓, 1,   Vim↓, 1,   ZO-1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 8,   angioG∅, 1,   EGFR↓, 3,   Endoglin↓, 1,   Hif1a↓, 1,   VEGF↓, 3,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   P-gp/ABCB1↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 1,   cellSen?, 1,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   CRP↓, 2,   FoxP3+↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 1,   IL10↓, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 1,   IL1β∅, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 11,   INF-γ↝, 1,   Inflam↓, 7,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 2,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 10,   T-Cell↑, 1,   TNF-α↓, 1,   TNF-α∅, 1,   VitD↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 2,   AR↝, 1,   DHT↓, 1,   EstroRS/ERS↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 9,   BioAv↝, 8,   BioEnh↑, 1,   ChemoSen↑, 6,   ChemoSen∅, 1,   CYP1A2↑, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 7,   Dose↝, 117,   Dose∅, 4,   eff↓, 2,   eff↑, 42,   eff↝, 6,   eff∅, 7,   Half-Life↑, 1,   Half-Life↝, 6,   RadioS↑, 4,   selectivity↑, 5,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALC↓, 1,   AR↓, 2,   AR↝, 1,   AST↓, 2,   BG↓, 1,   Bil∅, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   creat↓, 1,   CRP↓, 2,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   GutMicro↑, 1,   HemoG↑, 1,   IL6↓, 4,   Ki-67↓, 6,   Myc↓, 1,   PSA↓, 10,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 6,   antiNeop↑, 1,   AntiTum↑, 3,   AntiTum∅, 1,   cachexia↓, 1,   cardioP↑, 3,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 6,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 2,   memory↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   OS?, 1,   OS↑, 48,   OS↝, 1,   OS∅, 9,   Pain↓, 8,   QoL↑, 16,   QoL∅, 3,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   Risk↓, 13,   Risk↑, 2,   Risk↝, 2,   Risk∅, 4,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   toxicity↓, 25,   toxicity↑, 1,   toxicity↝, 19,   toxicity∅, 1,   TumVol↓, 4,   TumW↓, 1,   Weight↑, 5,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

CD8+↑, 3,   Diar↓, 1,   Diar⇅, 1,   Inf↓, 4,   Sepsis↓, 1,  
Total Targets: 277

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

12-HETE↓, 1,   2/16-OHE1↑, 1,   5-HETE↓, 1,   AcOH↑, 2,   AntiBio↑, 2,   BDI↓, 1,   Buty↑, 3,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   Eic↓, 1,   END↑, 1,   ENL↑, 1,   Eos↓, 1,   FEV1↑, 2,   FFA/NEFA↝, 1,   HRV↑, 1,   IgE↓, 1,   Ingr↝, 1,   IPSS↓, 1,   Learn↑, 1,   NLR↓, 1,   NMSS↓, 1,   PA↑, 2,   PCO↓, 1,   PEF↑, 1,   rHR↓, 1,   RT↓, 2,   SCFAs↑, 3,   SCFAs∅, 1,   Stress↓, 4,   Tinn↓, 1,   TMAO∅, 1,   UFR↑, 1,   UPDRS↓, 1,   UPDRSIII∅, 1,   UR↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 11,   Bil↓, 2,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   ROS↓, 16,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 3,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY↓, 1,   adiP↑, 1,   ALAT↓, 3,   ALAT∅, 1,   AMPK↑, 1,   CRM↑, 1,   DHA↑, 2,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDH↓, 3,   LDL↓, 9,   NH3↓, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   CK2↓, 1,   p38↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ach↑, 2,   AntiThr↑, 3,   other?, 3,   other↓, 3,   other↑, 16,   other↝, 14,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,   DNMT3A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   HDAC3↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   CRP↓, 4,   IFN-γ↓, 1,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 5,   IL4↑, 1,   IL4∅, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 5,   Inflam↓, 23,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   NF-kB↓, 1,   NK cell↑, 3,   PGE2↓, 2,   PSA↓, 1,   TNF-α↓, 8,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   AChE↓, 4,   BDNF↑, 7,   BDNF∅, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   tau↓, 3,   p‑tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

cortisol↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 4,   BioAv↑, 18,   BioAv↝, 12,   Dose?, 6,   Dose↓, 1,   Dose↑, 7,   Dose↝, 111,   eff↓, 1,   eff↑, 21,   eff↝, 7,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 19,   P450↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   ALAT∅, 1,   Albumin↑, 2,   ALP↓, 1,   AST↓, 1,   AST∅, 1,   Bil↓, 2,   BloodF↑, 3,   BMD↑, 1,   BP↓, 12,   BP∅, 1,   CRP↓, 4,   GutMicro↑, 6,   GutMicro∅, 1,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 1,   hs-CRP↓, 1,   IL6↓, 9,   LDH↓, 3,   PSA↓, 1,   TG/TAG↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↑, 2,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 2,   cardioP↑, 5,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 68,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 5,   memory↑, 23,   memory∅, 1,   Mood↑, 7,   motorD↑, 9,   MusCon↓, 1,   neuroP↑, 12,   Obesity↓, 2,   Pain↓, 8,   QoL?, 1,   QoL↑, 10,   RenoP↑, 3,   Risk↓, 5,   Risk↑, 2,   Risk↝, 1,   Sleep↑, 6,   Strength↑, 4,   toxicity?, 1,   toxicity↓, 31,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 7,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,  
Total Targets: 227

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page